ストックスクリーナーアプリを入手
19.42
0.54%
-0.105
前日終値:
$19.52
開ける：
$19.63
24時間の取引高:
1.62M
Relative Volume:
0.80
時価総額：
$1.33B
収益：
$1.01B
当期純損益:
$-204.71M
株価収益率:
-6.3276
EPS:
-3.0691
ネットキャッシュフロー:
$-29.67M
1週間 パフォーマンス:
-4.62%
1か月 パフォーマンス:
+3.24%
6か月 パフォーマンス:
+38.71%
1年 パフォーマンス:
-2.80%
1日の値動き範囲:
$19.18
$20.02
1週間の範囲:
$17.59
$20.49
52週間の値動き範囲:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
19.42 | 1.33B | 1.01B | -204.71M | -29.67M | -3.0691 |
ABT
Abbott Laboratories
|
89.46 | 158.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 120.69B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
80.00 | 103.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 85.62B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 48.14B | 6.30B | 1.07B | 1.34B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-19 | アップグレード | Truist | Hold → Buy |
| 2026-03-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | アップグレード | Lake Street | Hold → Buy |
| 2026-02-20 | アップグレード | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 再開されました | TD Cowen | Buy |
| 2025-12-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 再開されました | Stifel | Hold |
| 2025-09-08 | 開始されました | Oppenheimer | Outperform |
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
FDA flags high-risk recall for Tandem Diabetes Mobi pumps - MSN
TD Cowen Raises Tandem Diabetes (TNDM) Price Target, Keeps Buy Rating - Insider Monkey
Vanguard Capital Management files 13G for Tandem Diabetes Care (NYSE: TNDM) — 3.55M shares - Stock Titan
10 Best Medical Stocks to Buy Under $30 - Insider Monkey
MSN Money - MSN
Tandem Diabetes Care Announces Upcoming Conference Presentations - Yahoo Finance
Vanguard Portfolio Management (TNDM) reports 4.05M shares, 5.91% stake - Stock Titan
Tandem Diabetes Care Opens with 5.69% Gain, Outpacing S&P 500's 2.51% Increase - Markets Mojo
TNDM Stock Chart | TANDEM DIABETES CARE INC (NASDAQ:TNDM) - ChartMill
Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - MSN
TNDM Stock Price, Quote & Chart | TANDEM DIABETES CARE INC (NASDAQ:TNDM) - ChartMill
Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes - BioSpace
Tandem Diabetes Care (TNDM) Corporate presentation Summary - Quartr
FDA clears Control-IQ+AID technology for use in pregnancy complicated by type 1 diabetes - Contemporary OB/GYN
Tandem rises as Piper Sandler upgrades on pharmacy strategy - MSN
TNDM: Tandem Diabetes Receives FDA Approval for Control-IQ+ in P - GuruFocus
Tandem Diabetes’ Control-IQ+ Wins FDA Nod for T1D in Pregnancy - Medical Product Outsourcing
Tandem gains as Truist becomes latest to upgrade on new pharmacy model - MSN
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes upgraded at Citi on risk-reward setup - MSN
Stocks generating improved relative strength: Tandem Diabetes Care - MSN
Tandem Diabetes Care (TNDM) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Rothschild & Co Redburn Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
FDA flags most serious recall for Tandem Mobi insulin pumps - MSN
FDA Flags High-Risk Recall For Tandem Diabetes Mobi Pumps - Benzinga
(TNDM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
B of A Securities upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Tandem Diabetes Care Inc (TNDM) Stock Up 3.7% and Still Underval - GuruFocus
Tandem recalls Mobi insulin pumps over software malfunction - MedTech Dive
A Look at Tandem Diabetes Care Inc (TNDM) After 3.0% Gain -- GF Value $33.02 vs Price $21.24 - GuruFocus
TNDM Maintained by TD Cowen -- Price Target Raised to $28.00 - GuruFocus
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $28 - Moomoo
Tandem Diabetes stock price target raised to $28 by TD Cowen - Investing.com Canada
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $28 - Moomoo
Tandem (TNDM) Stock: Downside Risk Overview (Slight Rise) 2026-04-18ATR Levels - Cổng thông tin điện tử Tỉnh Sơn La
Tandem Diabetes (TNDM) COO exercises RSUs; shares withheld for taxes - Stock Titan
Tandem Diabetes Care Inc (TNDM) Shares Surge 4.8% -- What GF Score of 74 Tells Investors - GuruFocus
Mizuho Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $22 - Moomoo
Ideas Watch: Can Tandem Diabetes Care Inc continue delivering strong returnsPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Does Tandem Diabetes Care Inc have pricing power2026 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
(TNDM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
Tandem Diabetes Care Inc (TNDM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Mar 16 '26 |
Option Exercise |
0.00 |
7,414 |
0 |
43,383 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Mar 17 '26 |
Sale |
23.05 |
187 |
4,310 |
37,656 |
0.57%
1.14%
大文字化:
|
ボリューム (24 時間):